Trial Site Detail

 

Drug:
Regorafenib (BAY 73-4506)
Trial:
Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
No longer avalable

 

Huntsman Cancer Institute

2000 Circle of Hope     
Salt Lake City , UT 84103
USA

 

Principal Investigator:
Launce Gouw, MD, PhD
Contact:
launce.gouw@hsc.utah.edu 801-587-4643
Activation Status of this Site:
Closed
Notes about this Site:
Huntsman Cancer Institute Website:
http://oncore-app1.hci.utah.edu/sip-mobile/flowchart.html

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.